Effects of a calcium channel blocker and a statin-based treatment regimen in the Anglo-Scandinavian Cardiac Outcomes Trial [0.03%]
长效钙通道阻滞剂和他汀类治疗方案在血管紧张素转换酶抑制基础上的降压疗效：英国-斯堪的纳维亚心脏结局试验的事后分析
Michael J Bloch,Jan Basile
Michael J Bloch
Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) trial [0.03%]
氨氯地平与夸西利联用对比单用夸西利治疗糖尿病合并高血压：氨氯地平糖尿病研究(ANDI)
Sheldon Tobe,Kalina Kawecka-Jaszcz,Faiez Zannad et al.
Sheldon Tobe et al.
This randomized, comparative, parallel-group trial investigated strategies of blood pressure (BP)-lowering in patients with diabetes and hypertension. Patients not reaching goal BP (
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2007 Feb;9(2):120-7. DOI:10.1111/j.1524-6175.2007.06949.x 2007
Josiane Lima de Gusmão,Decio Mion Jr
Josiane Lima de Gusmão
Debbie L Cohen,Raymond R Townsend
Debbie L Cohen
George L Bakris,Matthew R Weir,Henry R Black
George L Bakris
A panel discussion was convened on November 10, 2006, to discuss methods of improving blood pressure control rates and future study focus. The expert panel was moderated by George L. Bakris, MD, Director, Hypertension Center, Endocrine Divi...
Jackson T Wright Jr,W Fitzhugh Brundage,Philip A Mackowiak
Jackson T Wright Jr
This case discussion was presented originally in an open forum on May 5, 2006, in Baltimore, MD, sponsored by the Department of Veterans Affairs Maryland Health Care System and the University of Maryland School of Medicine as part of an ong...
Explicit and implicit evaluation of physician adherence to hypertension guidelines [0.03%]
高血压指南依从性的显式和隐式评估
Gail Ardery,Barry L Carter,Jessica L Milchak et al.
Gail Ardery et al.
This study evaluated physician adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) hypertension guidelines in 6 community-based clinics. Explicit...
Evaluation of the dose response with valsartan and valsartan/hydrochlorothiazide in patients with essential hypertension [0.03%]
缬沙坦和缬沙坦/氢氯噻嗪治疗原发性高血压的剂量效应评估研究
Matthew R Weir,Nora Crikelair,Drew Levy et al.
Matthew R Weir et al.
This patient data meta-analysis included 9 randomized, double-blind, placebo-controlled trials (N=4278) of once-daily valsartan 80, 160, or 320 mg or valsartan/hydrochlorothiazide 80/12.5, 160/12.5, 160/25, 320/12.5, or 320/25 mg given for ...
British hypertension society recommends that beta-blockers are no longer indicated as initial treatment of hypertension: has the pendulum swung too far? [0.03%]
英国高血压学会推荐β受体阻滞剂不再作为高血压初始治疗药物：钟摆是否已经摇摆得太过？
Michael J Bloch
Michael J Bloch
Beta‐blockers are no longer preferred as a routine initial therapy for hypertension.—British Hypertensive Society Guidelines, 2006. 1
Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations [0.03%]
ACE抑制药与血管紧张素受体阻断剂联合治疗-未来展望
Domenic A Sica
Domenic A Sica
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are regularly prescribed for the management of hypertension. Each of these drug classes has also been shown to provide survival benefits for patients with heart fail...